These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Neonatal management of the very low birth weight infant: the use of surfactant. Martin GI; Sindel BD Clin Perinatol; 1992 Jun; 19(2):461-8. PubMed ID: 1617888 [TBL] [Abstract][Full Text] [Related]
6. The 5 W's of surfactant for respiratory distress syndrome of the premature infant. Parmigiani S J Matern Fetal Neonatal Med; 2004 Nov; 16 Suppl 2():25-7. PubMed ID: 15590430 [TBL] [Abstract][Full Text] [Related]
8. Curosurf. Med Lett Drugs Ther; 2000 Mar; 42(1074):27-8. PubMed ID: 10776410 [No Abstract] [Full Text] [Related]
9. Surfactant therapy in the USA: trials and current routines. Soll RF Biol Neonate; 1997; 71 Suppl 1():1-7. PubMed ID: 9209741 [No Abstract] [Full Text] [Related]
10. Surfactant for premature infants with respiratory distress. Med Lett Drugs Ther; 1990 Jan; 32(809):2-3. PubMed ID: 2294387 [No Abstract] [Full Text] [Related]
11. Replacement therapy with porcine natural surfactant--current status and future challenges. Report from the 8th International Workshop on Surfactant Replacement, Oslo, May 20-22, 1993. Saugstad OD; Halliday HL; Robertson B; Speer CP Biol Neonate; 1993; 64(5):269-78. PubMed ID: 7905289 [No Abstract] [Full Text] [Related]
12. Surfactant for the treatment of respiratory distress syndrome. Jobe A; Ikegami M Am Rev Respir Dis; 1987 Nov; 136(5):1256-75. PubMed ID: 3314618 [No Abstract] [Full Text] [Related]
13. [A case of severe respiratory distress syndrome treated with a surfactant of porcine origin (curosurf)]. Valls i Soler A; Román Echevarría L; Setién Aqueche G; López Heredia de Goya J An Esp Pediatr; 1990 Aug; 33(2):160-2. PubMed ID: 2275499 [No Abstract] [Full Text] [Related]
14. Exogenous surfactant in acute respiratory distress syndrome: more is better. Anzueto A Eur Respir J; 2002 May; 19(5):787-9. PubMed ID: 12030713 [No Abstract] [Full Text] [Related]
15. Evolution of pulmonary surfactants for the treatment of neonatal respiratory distress syndrome and paediatric lung diseases. Mazela J; Merritt TA; Gadzinowski J; Sinha S Acta Paediatr; 2006 Sep; 95(9):1036-48. PubMed ID: 16938747 [TBL] [Abstract][Full Text] [Related]
16. Advances with surfactant. Turell DC Emerg Med Clin North Am; 2008 Nov; 26(4):921-8, viii. PubMed ID: 19059091 [TBL] [Abstract][Full Text] [Related]
17. Impact of surfactant replacement therapy on the nursery. Nightengale B Neonatal Netw; 1992 Jun; 11(4):xiii-xvi. PubMed ID: 1608368 [No Abstract] [Full Text] [Related]
18. Surfactant status in preterm neonates recovering from respiratory distress syndrome. Verlato G; Cogo PE; Balzani M; Gucciardi A; Burattini I; De Benedictis F; Martiri G; Carnielli VP Pediatrics; 2008 Jul; 122(1):102-8. PubMed ID: 18595992 [TBL] [Abstract][Full Text] [Related]
19. Update on pulmonary surfactant replacement for neonates. Engel NS MCN Am J Matern Child Nurs; 1990; 15(3):189. PubMed ID: 2113980 [No Abstract] [Full Text] [Related]
20. The use of artificial surfactant (ALEC) in the prophylaxis of neonatal respiratory distress syndrome. Morley CJ Eur Respir J Suppl; 1989 Mar; 3():81s-86s. PubMed ID: 2663001 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]